Comparison of VEGF‐A values between pregnant women with COVID‐19 and healthy pregnancies and its association with composite adverse outcomes
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Medical Virology"
DOI: 10.1002/jmv.26631
Abstract: The aim is to compare VEGF‐A values between pregnant women with coronavirus disease 2019 (COVID‐19) and healthy controls. Furthermore, the association of inflammation parameters, disease severity, and obstetric complications with VEGF‐A was investigated. This prospective… read more here.
Keywords: women covid; composite adverse; pregnant women; vegf values ... See more keywords
Transcarotid Revascularization Outcomes Do Not Differ by Patient Age or Sex.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of vascular surgery"
DOI: 10.1016/j.jvs.2022.01.141
Abstract: BACKGROUND Transcarotid artery revascularization (TCAR) is a hybrid approach to carotid revascularization. There is limited information on differences in periprocedural complications and performance measures of TCAR in men compared to women, and in older compared… read more here.
Keywords: time; age; age sex; composite adverse ... See more keywords
Composite adverse outcomes in obstetric studies: a systematic review
Sign Up to like & getrecommendations! Published in 2021 at "BMC Pregnancy and Childbirth"
DOI: 10.1186/s12884-021-03588-w
Abstract: Background Composite outcomes are increasingly being used in obstetric trials. The aim of this systematic review is to critically appraise the use of composite outcomes in obstetric RCTs with an intention of identifying limitations and… read more here.
Keywords: outcomes obstetric; composite outcomes; composite adverse; systematic review ... See more keywords
In AF after TAVR, edoxaban was noninferior to VKAs for a composite of adverse events but increased major bleeding
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Internal Medicine"
DOI: 10.7326/j21-0014
Abstract: SOURCE CITATION Van Mieghem NM, Unverdorben M, Hengstenberg C, et al. Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR. N Engl J Med. 2021;385:2150-60. 34449183. read more here.
Keywords: tavr edoxaban; vkas composite; edoxaban noninferior; composite adverse ... See more keywords